• Breast Cancer Antigen CA 15-3
  • Small Nuclear Ribonucleoprotein Polypeptide N and Ubiquitin Protein Ligase E3A (SNRPN/UBE3A) Methylation Analysis
  • AFF2 (AF4/FMR2 family, member 2) Gene Mutation Analysis
  • Metanephrines, Urine
  • Antinuclear Antibody (ANA), IFA Patterning
  • CD4/CD8 Lymphocyte Ratio
  • 1p36.3 Microdeletion Syndrome, FISH
  • Platelet Count
  • Candida albicans, Antigen
  • Polycystic Kidney Disease, Autosomal Dominant (PKD1 and PKD2), Gene Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Thalassemia and Hemoglobinopathy Evaluation
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Thalassemia and Hemoglobinopathy Evaluation
Medical Test

Additional ICD10
Access to Thalassemia and Hemoglobinopathy Evaluation is restricted.
Loading...